Financial Report: HeartFlow with Loss in the Second Quarter
Eulerpool Research Systems •Sep 20, 2025
Takeaways NEW
- HeartFlow reported a loss of 9.2 million US dollars in the second quarter.
- The company generated revenue of $43.4 million in the same period.
HeartFlow, an innovative medical technology company based in Mountain View, California, reported a loss of $9.2 million in the second quarter. This corresponds to a loss of $1.46 per share, according to the company. Although the company had to accept a loss, HeartFlow generated revenue of $43.4 million in the same period. These figures illustrate the challenges and opportunities faced by medical technology companies today. A detailed analysis of these financial figures could provide insights into how HeartFlow can position itself in a dynamic market to overcome future challenges and capitalize on potential opportunities.
Eulerpool Markets
Finance Markets
New ReleaseEnterprise Grade
Institutional
Financial Data
Access comprehensive financial data with unmatched coverage and precision. Trusted by the world's leading financial institutions.
- 10M+ securities worldwide
- 100K+ daily updates
- 50-year historical data
- Comprehensive ESG metrics

Save up to 68%
vs. legacy vendors